08:15:30 EDT Sun 31 May 2026
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 24 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-05-31 08:06U:RVMDNews ReleaseRevolution Medicines Announces ASCO Plenary Presentation Highlighting Unprecedented Results from Pivotal Phase 3 RASolute 302 Clinical Trial of Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer
2026-05-31 08:00U:REPLNews ReleaseReplimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
2026-05-31 08:00U:PFENews ReleasePfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
2026-05-31 08:00U:LLYNews ReleaseLilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer
2026-05-31 08:00U:IMCRNews ReleaseImmunocore presents updated Phase 1 data of brenetafusp in patients with heavily pretreated advanced melanoma
2026-05-31 08:00U:GRALNews ReleaseGRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri(TM) Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting
2026-05-31 07:00U:SMXWNews ReleaseSMX and the Age of Parity: Certified Recycling Becomes the New Economics of Plastic
2026-05-31 07:00U:SMXNews ReleaseSMX and the Age of Parity: Certified Recycling Becomes the New Economics of Plastic
2026-05-30 22:45U:ELEKNews ReleaseAs Global Markets Discover Elektros, Microcap and Penny Stock Investors Are Beginning To Take Notice of a Growing EV Patent Technology and Lithium Mining Company
2026-05-30 22:15U:FUNNews ReleaseSIX FLAGS FIESTA TEXAS UNLEASHES WEREWOLF GORGE, THE WORLD'S LONGEST FAMILY LAUNCH ROLLER COASTER
2026-05-30 22:00U:ELEKNews ReleaseGlobal EV Charging Patent Update: Elektros Inc. Continues To Advance and Protect Its Intellectual Property as EV Infrastructure Opportunities Expand Worldwide
2026-05-30 21:15U:ELEKNews ReleaseGlobal Microcap Investors Are Discovering a Rare Diamond in the Rough
2026-05-30 20:42U:AUMMFNews ReleaseResults of Annual General Meeting
2026-05-30 17:24U:BAYZFNews ReleaseASCO 2026: Bayer Shares New Findings for NUBEQA(TM) (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial
2026-05-30 17:24U:BAYRYNews ReleaseASCO 2026: Bayer Shares New Findings for NUBEQA(TM) (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial
2026-05-30 14:30U:WHWKNews ReleaseWhitehawk Therapeutics Presents Real-World Analysis Confirming SEZ6 as a Highly Expressed, Clinically Relevant Target for SCLC and Other Neuroendocrine Tumors at ASCO 2026
2026-05-30 14:30U:PGENNews ReleasePrecigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
2026-05-30 14:30U:EIKNNews ReleaseEikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology
2026-05-30 14:15U:BNTXNews ReleaseGlobal Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
2026-05-30 12:03U:BWLPNews ReleaseBW LPG Enters Into Agreement for Eight 90'cbm Panamax Newbuildings with Hyundai Heavy Industries
2026-05-30 12:00U:MIRMNews ReleaseMirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
2026-05-30 11:15U:MLYSNews ReleaseMineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
2026-05-30 10:00U:EXELNews ReleaseExelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX(TM) (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
2026-05-30 08:30U:TEMNews ReleaseTempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community